The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury

Experimental Neurology

Volumn 258, Issue , 2014, Pages 121-129

  Schwab, Jan M ^a,b   Zhang, Yi ^c   Kopp, Marcel A ^a   Brommer, Benedikt ^a   Popovich, Phillip G ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Trauma Hospital Berlin (UKB)   (Germany)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Adaptive immune response; Autoimmunity; Innate immune response; Spinal cord injury

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; BUTOXAMINE; GABAPENTIN; MIFEPRISTONE; OCRELIZUMAB; RITUXIMAB;

ADAPTIVE IMMUNITY; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; AUTONOMIC DYSREFLEXIA; B LYMPHOCYTE; CEREBROVASCULAR ACCIDENT; COMPENSATORY ANTIINFLAMMATORY RESPONSE SYNDROME; DISEASE COURSE; DRUG EFFECT; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; IMMUNOMODULATION; IMMUNOREGULATION; INFECTION; INNATE IMMUNITY; LEUKOCYTE; MACROPHAGE; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPASTICITY; SPINAL CORD INJURY; SPINAL CORD INJURY INDUCED IMMUNE DEPRESSION SYNDROME; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T LYMPHOCYTE;

ADAPTIVE IMMUNE RESPONSE; AUTOIMMUNITY; INNATE IMMUNE RESPONSE; SPINAL CORD INJURY;

ANIMALS; AUTOIMMUNITY; CHRONIC DISEASE; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; INFLAMMATION MEDIATORS; SPINAL CORD INJURIES;

EID: 84904768726     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.04.023     Document Type: Review

References (109)

1. Ajmo C.T., Collier L.A., Leonardo C.C., Hall A.A., Green S.M., Womble T.A., Cuevas J., Willing A.E., Pennypacker K.R. Blockade of adrenoreceptors inhibits the splenic response to stroke. Exp. Neurol. 2009, 218:47-55.
2. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124(4):783-801. (Feb 24).
3. Ankeny D.P., Popovich P.G. B cells and autoantibodies: complex roles in CNS injury. Trends Immunol. 2010, 31:332-338.
4. Ankeny D.P., Lucin K.M., Sanders V.M., McGaughy V.M., Popovich P.G. Spinal cord injury triggers systemic autoimmunity: evidence for chronic B lymphocyte activation and lupus-like autoantibody synthesis. J. Neurochem. 2006, 99:1073-1087.
5. Ankeny D.P., Guan Z., Popovich P.G. B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice. J. Clin. Invest. 2009, 119:2990-2999.
6. Anthony D.C., Couch Y. The systemic reponse to CNS injury. Exp. Neurol. 2014, 258:105-111. (in this issue).
7. Beers D.R., Henkel J.S., Zhao W., Wang J., Huang A., Wen S., Liao B., Appel S.H. Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Brain 2011, 134(Pt 5):1293-1314. (May).
8. Bigford G.E., Bracchi-Ricard V.C., Keane R.W., Nash M.S., Bethea J.R. Neuroendocrine and cardiac metabolic dysfunction and NLRP3 inflammasome activation in adipose tissue and pancreas following chronic spinal cord injury in the mouse. ASN Neuro 2013, 5:243-255.
9. Blight A.R. Morphometric analysis of a model of spinal cord injury in guinea pigs, with behavioral evidence of delayed secondary pathology. J. Neurol. Sci. 1991, 103:156-171.
10. Bradl M., Bauer J., Flügel A., Wekerle H., Lassmann H. Complementary contribution of CD4 and CD8 T lymphocytes to T-cell infiltration of the intact and the degenerative spinal cord. Am. J. Pathol. 2005, 166(5):1441-1450. (May).
11. Brommer B., Engel E., Kopp M.A., Watzlawick R., Müller S., Failli V., Chen Y.Y., DeVivo M.J., Dirnagl U., Meisel A., Schwab J.M. Spinal Cord Injury increases the susceptibility for bacterial infection in a lesion height dependent manner-evidence for a neurogenic immune ablation ('immune paralysis') 2014, (in preparation).
12. Campagnolo D.I., Bartlett J.A., Keller S.E., Sanchez W., Oza R. Impaired phagocytosis of Staphylococcus aureus in complete tetraplegics. Am. J. Phys. Med. Rehabil. 1997, 76:276-280.
13. Cardona A.E., Pioro E.P., Sasse M.E., Kostenko V., Cardona S.M., Dijkstra I.M., Huang D., Kidd G., Dombrowski S., Dutta R., Lee J.C., Cook D.N., Jung S., Lira S.A., Littman D.R., Ransohoff R.M. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 2006, 9:917-924.
14. Cruse J.M., Lewis R.E., Bishop G.R., Kliesch W.F., Gaitan E., Britt R. Decreased immune reactivity and neuroendocrine alterations related to chronic stress in spinal cord injury and stroke patients. Pathobiology 1993, 61:183-192.
15. Cruse J.M., Keith J.C., Bryant M.L., Lewis R.E. Immune system-neuroendocrine dysregulation in spinal cord injury. Immunol. Res. 1996, 15:306-314.
16. Cunningham C., Wilcockson D.C., Campion S., Lunnon K., Perry V.H. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 2005, 25:9275-9284.
17. Davies A.L., Hayes K.C., Dekaban G.A. Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury. Arch. Phys. Med. Rehabil. 2007, 88:1384-1393.
18. Detloff M.R., Fisher L.C., McGaughy V., Longbrake E.E., Popovich P.G., Basso D.M. Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats. Exp. Neurol. 2008, 212:337-347.
19. DeVivo M.J., Kartus P.L., Stover S.L., Rutt R.D., Fine P.R. Cause of death for patients with spinal cord injuries. Arch. Intern. Med. 1989, 149:1761-1766.
20. Dietz V., Fouad K. Restoration of sensorimotor functions after spinal cord injury. Brain 2014, 137(Pt 3):654-667. (Mar).
21. Donnelly D.J., Popovich P.G. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp. Neurol. 2008, 209:378-388.
22. Dulin J.N., Karoly E.D., Wang Y., Strobel H.W., Grill R.J. Licofelone modulates neuroinflammation and attenuates mechanical hypersensitivity in the chronic phase of spinal cord injury. J. Neurosci. 2013, 33:652-664.
23. Dusart I., Schwab M.E. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur. J. Neurosci. 1994, 6:712-724.
24. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 2000, 52:595-638.
25. Engeland W.C., Arnhold M.M. Neural circuitry in the regulation of adrenal corticosterone rhythmicity. Endocrine 2005, 28:325-332.
26. Enouz S., Carrié L., Merkler D., Bevan M.J., Zehn D. Autoreactive T cells bypass negative selection and respond to self-antigen stimulation during infection. J. Exp. Med. 2012, 209:1769-1779.
27. Failli V., Kopp M.A., Gericke C., Martus P., Klingbeil S., Brommer B., Laginha I., Chen Y., DeVivo M.J., Dirnagl U., Schwab J.M. Functional neurological recovery after spinal cord injury is impaired in patients with infections. Brain 2012, 135:3238-3250.
28. Fleming J.C., Norenberg M.D., Ramsay D.A., Dekaban G.A., Marcillo A.E., Saenz A.D., Pasquale-Styles M., Dietrich W.D., Weaver L.C. The cellular inflammatory response in human spinal cords after injury. Brain 2006, 129:3249-3269.
29. Franciotta D., Salvetti M., Lolli F., Serafini B., Aloisi F. B cells and multiple sclerosis. Lancet Neurol. 2008, 7(9):852-858. (Sep).
30. Freund P., Weiskopf N., Ashburner J., Wolf K., Sutter R., Altmann D.R., Friston K., Thompson A., Curt A. MRI investigation of the sensorimotor cortex and the corticospinal tract after acute spinal cord injury: a prospective longitudinal study. Lancet Neurol. 2013, 12:873-881.
31. Furlan J.C., Krassioukov A.V., Fehlings M.G. Hematologic abnormalities within the first week after acute isolated traumatic cervical spinal cord injury: a case-control cohort study. Spine (Phila Pa 1976) 2006, 31(23):2674-2683. (Nov 1).
32. George R., Griffin J.W. Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: the dorsal radiculotomy model. Exp. Neurol. 1994, 129:225-236.
33. Gilbert O., Croffoot J.R., Taylor A.J., Nash M., Schomer K., Groah S. Serum lipid concentrations among persons with spinal cord injury-a systematic review and meta-analysis of the literature. Atherosclerosis 2014, 232:305-312.
34. Gold R., Stangel M., Dalakas M.C. Drug Insight: the use of intravenous immunoglobulin in neurology-therapeutic considerations and practical issues. Nat. Clin. Pract. Neurol. 2007, 3:36-44.
35. Hains B.C., Waxman S.G. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J. Neurosci. 2006, 26:4308-4317.
36. Hayes K.C., Hull T.C., Delaney G.A., Potter P.J., Sequeira K.A., Campbell K., Popovich P.G. Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury. J. Neurotrauma 2002, 19(6):753-761. (Jun).
37. Hotchkiss R.S., Monneret G., Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect. Dis. 2013, 3:260-268.
38. Hotchkiss R.S., Monneret G., Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 2013, 13:862-874.
39. Irwin M.R., Cole S.W. Reciprocal regulation of the neural and innate immune systems. Nat. Rev. Immunol. 2011, 11:625-632.
40. Jones T.B. Lymphocytes and autoimmunity after SCI. Exp. Neurol 2014, 258:78-90. (in this issue).
41. Jones T.B., Basso D.M., Sodhi A., Pan J.Z., Hart R.P., MacCallum R.C., Lee S., Whitacre C.C., Popovich P.G. Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. J. Neurosci. 2002, 22:2690-2700.
42. Jones T.B., Hart R.P., Popovich P.G. Molecular control of physiological and pathological T-cell recruitment after mouse spinal cord injury. J. Neurosci. 2005, 25:6576-6583.
43. Kigerl K.A., McGaughy V.M., Popovich P.G. Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury. J. Comp. Neurol. 2006, 494:578-594.
44. Kigerl, et al. Pattern recognition receptors and central nervous system repair. Exp. Neurol. 2014, 258:5-16. (in this issue).
45. Kil K., Zang Y.C., Yang D., Markowski J., Fuoco G.S., Vendetti G.C., Rivera V.M., Zhang J.Z. T cell responses to myelin basic protein in patients with spinal cord injury and multiple sclerosis. J. Neuroimmunol. 1999, 98:201-207.
46. Kopp M.A., Druschel C., Meisel C., Liebscher T., Prilipp E., Watzlawick R., Cinelli P., Niedeggen A., Schaser K.D., Wanner G.A., Curt A., Lindemann G., Nugaeva N., Fehlings M.G., Vajkoczy P., Cabraja M., Dengler J., Ertel W., Ekkernkamp A., Martus P., Volk H.D., Unterwalder N., Kölsch U., Brommer B., Hellmann R.C., Ossami Saidy R.R., Laginha I., Prüss H., Failli V., Dirnagl U., Schwab J.M. The SCIentinel study-prospective multicenter study to define the spinal cord injury-induced immune depression syndrome (SCI-IDS)-study protocol and interim feasibility data. BMC Neurol. 2013, 13:168.
47. Lassmann H., Brück W., Lucchinetti C.F. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 2007, 17:210-218.
48. Lin Y., Vreman H.J., Wong R.J., Tjoa T., Yamauchi T., Noble-Haeusslein L.J. Heme oxygenase-1 stabilizes the blood-spinal cord barrier and limits oxidative stress and white matter damage in the acutely injured murine spinal cord. J. Cereb. Blood Flow Metab. 2007, 27:1010-1021.
49. Lucin K.M., Wyss-Coray T. Immune activation in brain aging and neurodegeneration: too much or too little?. Neuron 2009, 64:110-122.
50. Lucin K.M., Sanders V.M., Jones T.B., Malarkey W.B., Popovich P.G. Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation. Exp. Neurol. 2007, 207:75-84.
51. Lucin K.M., Sanders V.M., Popovich P.G. Stress hormones collaborate to induce lymphocyte apoptosis after high level spinal cord injury. J. Neurochem. 2009, 110:1409-1421.
52. Mackay F., Schneider P., Rennert P., Browning J. BAFF AND APRIL: a tutorial on B cell survival. Annu. Rev. Immunol. 2003, 21:231-264.
53. Magliozzi R., Howell O., Vora A., Serafini B., Nicholas R., Puopolo M., Reynolds R., Aloisi F. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007, 130(Pt 4):1089-1104. (Apr).
54. Magliozzi R., Howell O.W., Reeves C., Roncaroli F., Nicholas R., Serafini B., Aloisi F., Reynolds R. A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann. Neurol. 2010, 68:477-493.
55. Magnus T., Chan A., Savill J., Toyka K.V., Gold R. Phagocytotic removal of apoptotic, inflammatory lymphocytes in the central nervous system by microglia and its functional implications. J. Neuroimmunol. 2002, 130:1-9.
56. Martin F., Chan A.C. B cell immunobiology in disease: evolving concepts from the clinic. Annu. Rev. Immunol. 2006, 24:467-496.
57. Matsushita T., Horikawa M., Iwata Y., Tedder T.F. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J. Immunol. 2010, 185:2240-2252.
58. McGonagle D., McDermott M.F. A proposed classification of the immunological diseases. PLoS Med. 2006, 3:e297.
59. Meisel C., Schwab J.M., Prass K., Meisel A., Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat. Rev. Neurosci. 2005, 6:775-786.
60. Meuth S.G., Simon O.J., Grimm A., Melzer N., Herrmann A.M., Spitzer P., Landgraf P., Wiendl H. CNS inflammation and neuronal degeneration is aggravated by impaired CD200-CD200R-mediated macrophage silencing. J. Neuroimmunol. 2008, 194:62-69.
61. Mizrachi Y., Ohry A., Aviel A., Rozin R., Brooks M.E., Schwartz M. Systemic humoral factors participating in the course of spinal cord injury. Paraplegia 1983, 21:287-293.
62. Moreno B., Jukes J.P., Vergara-Irigaray N., Errea O., Villoslada P., Perry V.H., Newman T.A. Systemic inflammation induces axon injury during brain inflammation. Ann. Neurol. 2011, 70:932-942.
63. Muñoz L.E., Lauber K., Schiller M., Manfredi A.A., Herrmann M. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat. Rev. Rheumatol. 2010, 6:280-289.
64. Nagata S., Hanayama R., Kawane K. Autoimmunity and the clearance of dead cells. Cell 2010, 140:619-630.
65. Nance D.M., Sanders V.M. Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav. Immun. 2007, 21:736-745.
66. Nathan C., Ding A. Nonresolving inflammation. Cell 2010, 140:871-882.
67. Nguyen D.H., Cho N., Satkunendrarajah K., Austin J.W., Wang J., Fehlings M.G. Immunoglobulin G (IgG) attenuates neuroinflammation and improves neurobehavioral recovery after cervical spinal cord injury. J. Neuroinflammation 2012, 9:224.
68. Ohri S.S., Maddie M.A., Zhao Y., Qiu M.S., Hetman M., Whittemore S.R. Attenuating the endoplasmic reticulum stress response improves functional recovery after spinal cord injury. Glia. 2011, 59(10):1489-1502. (Oct).
69. Perry V.H., Newman T.A., Cunningham C. The impact of systemic i nfection on the progression of neurodegenerative disease. Nat. Rev. Neurosci. 2003, 4:103-112.
70. Popovich P.G. Immunological regulation of neuronal degeneration and regeneration in the injured spinal cord. Prog. Brain Res. 2000, 128:43-58.
71. Popovich P.G., Longbrake E.E. Can the immune system be harnessed to repair the CNS?. Nat. Rev. Neurosci. 2008, 9(6):481-493. (Jun).
72. Popovich P., McTigue D. Damage control in the nervous system: beware the immune system in spinal cord injury. Nat. Med. 2009, 15:736-737.
73. Popovich P.G., Stokes B.T., Whitacre C.C. Concept of autoimmunity following spinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system. J. Neurosci. Res. 1996, 45:349-363.
74. Popovich P.G., Horner P.J., Mullin B.B., Stokes B.T. A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury. Exp. Neurol. 1996, 142:258-275.
75. Popovich P.G., Wei P., Stokes B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 1997, 377:443-464.
76. Poser C.M. The role of trauma in the pathogenesis of multiple sclerosis: a review. Clin. Neurol. Neurosurg. 1994, 96:103-110.
77. Prass K., Meisel C., Hoflich C., Braun J., Halle E., Wolf T., Ruscher K., Victorov I.V., Priller J., Dirnagl U., Volk H.D., Meisel A. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J. Exp. Med. 2003, 198:725-736.
78. Prüss H., Kopp M.A., Brommer B., Gatzemeier N., Laginha I., Dirnagl U., Schwab J.M. Non-resolving aspects of acute inflammation after spinal cord injury (SCI): indices and resolution plateau. Brain Pathol. 2011, 21:652-660.
79. Prüss H., Rosche B., Sullivan A.B., Brommer B., Wengert O., Gronert K., Schwab J.M. Proresolution lipid mediators in multiple sclerosis-differential, disease severity-dependent synthesis-a clinical pilot trial. PLoS One 2013, 8:e55859.
80. Qiao F., Atkinson C., Song H., Pannu R., Singh I., Tomlinson S. Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma. Am. J. Pathol. 2006, 169:1039-1047.
81. Rabchevsky A.G., Patel S.P., Lyttle T.S., Eldahan K.C., O'Dell C.R., Zhang Y., Popovich P.G., Kitzman P.H., Donohue K.D. Effects of gabapentin on muscle spasticity and both induced as well as spontaneous autonomic dysreflexia after complete spinal cord injury. Front. Physiol. 2012, 3:329.
82. Rice T., Larsen J., Rivest S., Yong V.W. Characterization of the early neuroinflammation after spinal cord injury in mice. J. Neuropathol. Exp. Neurol. 2007, 66:184-195.
83. Rice C.M., Cottrell D., Wilkins A., Scolding N.J. Primary progressive multiple sclerosis: progress and challenges. J. Neurol. Neurosurg. Psychiatry 2013, 84:1100-1106.
84. Riegger T., Conrad S., Liu K., Schluesener H.J., Adibzahdeh M., Schwab J.M. Spinal cord injury-induced immune depression syndrome (SCI-IDS). Eur. J. Neurosci. 2007, 25:1743-1747.
85. Riegger T., Conrad S., Schluesener H.J., Kaps H.P., Badke A., Baron C., Gerstein J., Dietz K., Abdizahdeh M., Schwab J.M. Immune depression syndrome following human spinal cord injury (SCI): a pilot study. Neuroscience 2009, 158:1194-1199.
86. Rosenberg L.J., Zai L.J., Wrathall J.R. Chronic alterations in the cellular composition of spinal cord white matter following contusion injury. Glia 2005, 49:107-120.
87. Saltzman J.W., Battaglino R.A., Salles L., Jha P., Sudhakar S., Garshick E., Stott H.L., Zafonte R., Morse L.R. B-cell maturation antigen, a proliferation-inducing ligand, and B-cell activating factor are candidate mediators of spinal cord injury-induced autoimmunity. J. Neurotrauma 2013, 30:434-440.
88. Savill J., Dransfield I., Gregory C., Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2002, 2:965-975.
89. Schwab J.M., Brechtel K., Nguyen T.D., Schluesener H.J. Persistent accumulation of cyclooxygenase-1 (COX-1) expressing microglia/macrophages and upregulation by endothelium following spinal cord injury. J. Neuroimmunol. 2000, 111:122-130.
90. Schwab J.M., Frei E., Klusman I., Schnell L., Schwab M.E., Schluesener H.J. AIF-1 expression defines a proliferating and alert microglial/macrophage phenotype following spinal cord injury in rats. J. Neuroimmunol. 2001, 119(2):214-222. (Oct 1).
91. Schwab J.M., Guo L., Schluesener H.J. Spinal cord injury induces early and persistent lesional P2X4 receptor expression. J. Neuroimmunol. 2005, 163:185-189.
92. Schwab J.M., Brechtel K., Mueller C.A., Failli V., Kaps H.P., Tuli S.K., Schluesener H.J. Experimental strategies to promote spinal cord regeneration-an integrative perspective. Prog. Neurobiol. 2006, 78(2):91-116. (Feb).
93. Schwab J.M., Chiang N., Arita M., Serhan C.N. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 2007, 447:869-874.
94. Schwartz M., Kipnis J. Therapeutic T cell-based vaccination for neurodegenerative disorders: the role of CD4+CD25+ regulatory T cells. Ann. N. Y. Acad. Sci. 2005, 1051:701-708.
95. Serhan C.N., Savill J. Resolution of inflammation: the beginning programs the end. Nat. Immunol. 2005, 6:1191-1197.
96. Serhan C.N., Brain S.D., Buckley C.D., Gilroy D.W., Haslett C., O'Neill L.A., Perretti M., Rossi A.G., Wallace J.L. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 2007, 21:325-332.
97. Soden R.J., Walsh J., Middleton J.W., Craven M.L., Rutkowski S.B., Yeo J.D. Causes of death after spinal cord injury. Spinal Cord 2000, 38:604-610.
98. Sullivan P.G., Rabchevsky A.G., Waldmeier P.C., Springer J.E. Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death?. J. Neurosci. Res. 2005, 79(1-2):231-239. (Jan 1-15).
99. Taranova N.P., Makarov A., Amelina O.A., Luchakova O.S., Loboda E.B., Leǐkin I.B. The production of autoantibodies to nerve tissue glycolipid antigens in patients with traumatic spinal cord injuries. Zh. Vopr. Neirokhir. Im. N. N. Burdenko 1992, 4-5:21-24. (Russian).
100. Teeling J.L., Cunningham C., Newman T.A., Perry V.H. The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: Implications for a role of COX-1. Brain Behav. Immun. 2010, 24:409-419.
101. Uderhardt S., Herrmann M., Oskolkova O.V., Aschermann S., Bicker W., Ipseiz N., Sarter K., Frey B., Rothe T., Voll R., Nimmerjahn F., Bochkov V.N., Schett G., Krönke G. 12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance. Immunity 2012, 36:834-846.
102. Vallières N., Berard J.L., David S., Lacroix S. Systemic injections of lipopolysaccharide accelerates myelin phagocytosis during Wallerian degeneration in the injured mouse spinal cord. Glia 2006, 53:103-113.
103. Vargas M.E., Watanabe J., Singh S.J., Robinson W.H., Barres B.A. Endogenous antibodies promote rapid myelin clearance and effective axon regeneration after nerve injury. Proc. Natl. Acad. Sci. U. S. A. 2010, A107:11993-11998.
104. Wright B.R., Warrington A.E., Edberg D.D., Rodriguez M. Cellular mechanisms of central nervous system repair by natural autoreactive monoclonal antibodies. Arch. Neurol. 2009, 66:1456.
105. Wu B., Matic D., Djogo N., Szpotowicz E., Schachner M., Jakovcevski I. Improved regeneration after spinal cord injury in mice lacking functional T- and B-lymphocytes. Exp. Neurol. 2012, 237:274-285.
106. Xu X., Warrington A.E., Wright B.R., Bieber A.J., Van Keulen V., Pease L.R., Rodriguez M. A human IgM signals axon outgrowth: coupling lipid raft to microtubules. J. Neurochem. 2011, 119:100-112.
107. Zajarías-Fainsod D., Carrillo-Ruiz J., Mestre H., Grijalva I., Madrazo I., Ibarra A. Autoreactivity against myelin basic protein in patients with chronic paraplegia. Eur. Spine J. 2012, 21:964-970.
108. Zhang Y., Guan Z., Reader B., Shawler T., Mandrekar-Colucci S., Huang K., Weil Z., Bratasz A., Wells J., Powell N.D., Sheridan J.F., Whitacre C.C., Rabchevsky A.G., Nash M.S., Popovich P.G. Autonomic dysreflexia causes chronic immune suppression after spinal cord injury. J. Neurosci. 2013, 33:12970-12981.
109. Zhao P., Waxman S.G., Hains B.C. Modulation of thalamic nociceptive processing after spinal cord injury through remote activation of thalamic microglia by cysteine cysteine chemokine ligand 21. J. Neurosci. 2007, 27:8893-8902.